Alopecia Areata After Initiation of Secukinumab Therapy for Plaque Psoriasis

    May 2023 in “ Cureus ”
    Esther Choi, Olivia Thomson, David W. Smith
    Studysummary In this case report, a 64-year-old woman developed alopecia areata after starting the IL-17A inhibitor secukinumab for psoriasis, highlighting a potential rare side effect of this treatment, with only three similar cases reported in the literature.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on assets.cureus.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Alopecia Diffusa While Using Interleukin-17 Inhibitors Against Psoriasis Vulgaris Case Reports in Dermatology · 2019
    2. Alopecia Areata: A Multifactorial Autoimmune Condition Journal of autoimmunity · 2018
    3. IL-17 Inhibition: Is It the Long-Awaited Savior for Alopecia Areata? Archives of Dermatological Research · 2018